Ageing bodies need to get rid of decrepit cells
Senolytics and cellular rejuvenation could hold the key | Technology Quarterly
Stay updated with breaking news from Translational Geroscience Network. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Senolytics and cellular rejuvenation could hold the key | Technology Quarterly
The Buck Institute for Research on Aging has received a $3.5 million federal grant to lead the first-ever double-blind, randomized, placebo-controlled clinical trial to understand the effects of ketone ester supplementation on frailty, a condition of vulnerability which develops following age-related decline in multiple physiological systems.
Scientists at Wake Forest University School of Medicine are reporting results from a Phase I trial in an area of promising research for Alzheimer's disease—cellular senescence.
Scientists at Wake Forest University School of Medicine are reporting results from a Phase I trial in an area of promising research for Alzheimer's disease—cellular senescence.
Researchers are investigating medicines that selectively kill decrepit cells to promote healthy aging